Skip to search Skip to main content
  • About Us
    Vision Our Story Technology Focus Areas Our Team
  • Access
    Policies Guides Events COVID-19 Advisory
  • Collections
    Books & Journals A-Z listing Special Collections
  • Contact Us
  1. Jio Institute Digital Library
  2. Searchworks

Searchworks

Select search scope, currently: Articles
  • Catalog
    books, media & more in Jio Institute collections
  • Articles
    journal articles & other e-resources

Help
Contact
Covid-19 Advisory
Policies
  • Bookmarks 0
  • Search history
  • Sign in

Cite

Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.

MLA

Miyazaki Y, et al. “Maximum Standard Uptake Value of 18F-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Progression-Free Survival of Newly Diagnosed Patients with Diffuse Large B Cell Lymphoma.” Annals of Hematology, vol. 92, no. 2, Jan. 2013, pp. 239–44. EBSCOhost, https://doi.org/10.1007/s00277-012-1602-3.



APA

Miyazaki Y, Nawa Y, Miyagawa M, Kohashi S, Nakase K, Yasukawa M, Hara M, Miyazaki, Y., Nawa, Y., Miyagawa, M., Kohashi, S., Nakase, K., Yasukawa, M., & Hara, M. (2013). Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma. Annals of Hematology, 92(2), 239–244. https://doi.org/10.1007/s00277-012-1602-3



Chicago

Miyazaki Y, Nawa Y, Miyagawa M, Kohashi S, Nakase K, Yasukawa M, Hara M, et al. 2013. “Maximum Standard Uptake Value of 18F-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Progression-Free Survival of Newly Diagnosed Patients with Diffuse Large B Cell Lymphoma.” Annals of Hematology 92 (2): 239–44. doi:10.1007/s00277-012-1602-3.

Contact
Covid-19 Advisory
Policies
About Us
Academics
Research
Campus Life
Contact
T&C
Privacy Policy